Pfizer C3671017

Study Details

Full Title

A PHASE 3 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND
IMMUNOGENICITY OF A RESPIRATORY SYNCYTIAL VIRUS VACCINE IN
CHILDREN AT HIGH RISK OF RSV DISEASE

Principal Investigator

Michael
Smith

Protocol Number

PRO00121136

Phase

III

Enrollment Status

Open to Enrollment